Long‐term safety and efficacy of lacosamide and controlled‐release carbamazepine monotherapy in patients with newly diagnosed epilepsy

OBJECTIVE: A large‐scale, double‐blind trial (SP0993; NCT01243177) demonstrated that lacosamide was noninferior to controlled‐release carbamazepine (carbamazepine‐CR) in terms of efficacy, and well tolerated as first‐line monotherapy in patients (≥16 years of age) with newly diagnosed epilepsy. We r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben‐Menachem, Elinor, Grebe, Hans Peter, Terada, Kiyohito, Jensen, Lori, Li, Ting, De Backer, Marc, Steiniger‐Brach, Björn, Gasalla, Teresa, Brock, Melissa, Biton, Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Full‐length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988520/
https://www.ncbi.nlm.nih.gov/pubmed/31755090
http://dx.doi.org/10.1111/epi.16381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988520/
https://www.ncbi.nlm.nih.gov/pubmed/31755090
http://dx.doi.org/10.1111/epi.16381

Ejemplares similares